Stay updated on Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Sign up to get notified when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.

Latest updates to the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study history page version was updated from v3.6.5 to v3.6.6, representing a new revision of the page. This update does not change the visible content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page history now shows Revision: v3.6.5 replacing v3.6.4, indicating a deployment update to the ClinicalTrials.gov page rather than changes to study details.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.6.4 is added to the page history, replacing v3.6.3. This reflects a platform update rather than changes to the study content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now shows Revision: v3.6.3, updating the revision history to reflect a newer page version.SummaryDifference0.1%

- Check73 days agoChange DetectedThe record history shows a new system revision label v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check87 days agoChange DetectedRecruitment status changed to 'No longer looking for participants,' indicating enrollment has ended. The page history also notes a new release version, v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.